ADMA Other | ADMA BIOLOGICS, INC.

ADMA BIOLOGICS, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2026-02-25: Form 10-K; Item Stock registered under Section 12(b); As filed Common stock, par value $0.0001 per share · ADMA · NASDAQ.
2025-03-18: Form 10-K; Item Stock registered under Section 12(b); As filed Common stock, par value $0.0001 per share · ADMA · NASDAQ.
2024-08-08: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock · ADMA · Nasdaq Global Market.
2024-05-09: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock · ADMA · Nasdaq Global Market.

Filed	Form	Item	As filed
2026-02-25	10-K	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · ADMA · NASDAQ
2025-03-18	10-K	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · ADMA · NASDAQ
2024-08-08	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2024-05-09	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2024-02-28	10-K	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · ADMA · Nasdaq Global Market
2024-02-28	10-K	Smaller reporting company	Yes
2023-11-08	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2023-11-08	10-Q	Smaller reporting company	Yes
2023-08-09	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2023-08-09	10-Q	Smaller reporting company	Yes
2023-05-10	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2023-05-10	10-Q	Smaller reporting company	Yes
2023-03-23	10-K	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · ADMA · Nasdaq Global Market
2023-03-23	10-K	Smaller reporting company	Yes
2023-03-23	10-K	Well-known seasoned issuer	No
2022-11-09	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2022-11-09	10-Q	Smaller reporting company	Yes
2022-08-10	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2022-08-10	10-Q	Smaller reporting company	Yes
2022-05-11	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2022-05-11	10-Q	Stock registered under Section 12(b)	Preferred Share Purchase Right · Nasdaq Global Market
2022-05-11	10-Q	Smaller reporting company	Yes
2022-03-24	10-K	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · ADMA · Nasdaq Global Market
2022-03-24	10-K	Stock registered under Section 12(b)	Preferred Share Purchase Right · Nasdaq Global Market
2022-03-24	10-K	Smaller reporting company	Yes
2022-03-24	10-K	Well-known seasoned issuer	No
2021-11-10	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2021-11-10	10-Q	Stock registered under Section 12(b)	Preferred Share Purchase Right · Nasdaq Global Market
2021-11-10	10-Q	Smaller reporting company	Yes
2021-08-11	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2021-08-11	10-Q	Stock registered under Section 12(b)	Preferred Share Purchase Right · Nasdaq Global Market
2021-08-11	10-Q	Smaller reporting company	Yes
2021-05-12	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2021-05-12	10-Q	Stock registered under Section 12(b)	Preferred Share Purchase Right · Nasdaq Global Market
2021-05-12	10-Q	Smaller reporting company	Yes
2021-03-25	10-K	Stock registered under Section 12(b)	Common stock, par value $0.0001 per share · Nasdaq Global Market
2021-03-25	10-K	Stock registered under Section 12(b)	Preferred Share Purchase Right · Nasdaq Global Market
2021-03-25	10-K	Smaller reporting company	Yes
2021-03-25	10-K	Well-known seasoned issuer	No
2020-11-05	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2020-11-05	10-Q	Smaller reporting company	Yes
2020-08-05	10-Q	Stock registered under Section 12(b)	Common Stock · ADMA · Nasdaq Global Market
2020-08-05	10-Q	Smaller reporting company	Yes
2020-05-06	10-Q	Smaller reporting company	Yes
2020-03-13	10-K	Public float as of 2020-06-30	$158.69M
2020-03-13	10-K	Smaller reporting company	Yes
2020-03-13	10-K	Well-known seasoned issuer	No
2019-11-06	10-Q	Smaller reporting company	Yes
2019-08-08	10-Q	Smaller reporting company	Yes
2019-05-08	10-Q	Smaller reporting company	Yes
2019-03-13	10-K	Smaller reporting company	Yes
2019-03-13	10-K	Well-known seasoned issuer	No
2018-11-09	10-Q	Smaller reporting company	Yes
2018-11-09	10-Q	Emerging growth company	Yes
2018-08-10	10-Q	Well-known seasoned issuer	No
2018-05-14	10-Q	Well-known seasoned issuer	No
2018-03-29	10-K	Well-known seasoned issuer	No
2017-11-03	10-Q	Well-known seasoned issuer	No
2017-08-11	10-Q	Well-known seasoned issuer	No
2017-05-12	10-Q	Well-known seasoned issuer	No
2017-02-24	10-K	Well-known seasoned issuer	No
2016-11-10	10-Q	Well-known seasoned issuer	No
2016-08-12	10-Q	Well-known seasoned issuer	No
2016-05-13	10-Q	Well-known seasoned issuer	No
2016-03-23	10-K	Well-known seasoned issuer	No
2015-11-10	10-Q	Well-known seasoned issuer	No
2015-08-11	10-Q	Well-known seasoned issuer	No
2015-05-12	10-Q	Well-known seasoned issuer	No
2015-03-09	10-K	Well-known seasoned issuer	No
2014-11-10	10-Q	Well-known seasoned issuer	No
2014-08-11	10-Q	Well-known seasoned issuer	No
2014-05-12	10-Q	Well-known seasoned issuer	No
2014-03-28	10-K	Well-known seasoned issuer	No
2013-11-12	10-Q	Well-known seasoned issuer	No
2013-08-12	10-Q	Well-known seasoned issuer	No
2013-05-14	10-Q	Well-known seasoned issuer	No
2013-03-06	10-K	Well-known seasoned issuer	No
2012-11-13	10-Q	Well-known seasoned issuer	No
2012-08-14	10-Q	Well-known seasoned issuer	No
2012-05-15	10-Q	Well-known seasoned issuer	No

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Kodiak Sciences Inc. (KOD)	United States	$2.090B	-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)	United States	$2.175B	-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)	United States	$2.080B	-3.78
Vericel Corp (VCEL)	United States	$2.011B	93.97
Greenland Mines Ltd (GRML)	United States	$2.362B
Vir Biotechnology, Inc. (VIR)	United States	$1.814B	-6.85
NOVAVAX INC (NVAX)	United States	$1.748B	-6.26
Beam Therapeutics Inc. (BEAM)	United States	$2.549B	-41.51
Hemab Therapeutics Holdings, Inc. (COAG)	United States	$1.672B
Immunocore Holdings plc (IMCR)		$1.613B	-90.43